INmune Bio, Inc. (INMB) Tops Q2 EPS by 14c
Get Alerts INMB Hot Sheet
Join SI Premium – FREE
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.05), $0.14 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- NeuroPace (NPCE) Tops Q2 EPS by 3c
- Stabilis Solutions, Inc. (SLNG) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share